These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 36091032)
1. A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19. Singh S; Saavedra-Avila NA; Tiwari S; Porcelli SA Front Immunol; 2022; 13():959656. PubMed ID: 36091032 [TBL] [Abstract][Full Text] [Related]
2. Natural and trained innate immunity against Mycobacterium tuberculosis. Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788 [TBL] [Abstract][Full Text] [Related]
3. Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective. Setiabudiawan TP; Reurink RK; Hill PC; Netea MG; van Crevel R; Koeken VACM Med; 2022 Jan; 3(1):6-24. PubMed ID: 35590145 [TBL] [Abstract][Full Text] [Related]
4. Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guérin vaccination. Silver RF; Xia M; Storer CE; Jarvela JR; Moyer MC; Blazevic A; Stoeckel DA; Rakey EK; Tennant JM; Goll JB; Head RD; Hoft DF Nat Commun; 2023 Dec; 14(1):8507. PubMed ID: 38129388 [TBL] [Abstract][Full Text] [Related]
5. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice. Li W; Li M; Deng G; Zhao L; Liu X; Wang Y Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477 [TBL] [Abstract][Full Text] [Related]
7. Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency. Siddiqui KF; Amir M; Khan N; Rama Krishna G; Sheikh JA; Rajagopal K; Agrewala JN Clin Exp Immunol; 2015 Aug; 181(2):286-96. PubMed ID: 25845290 [TBL] [Abstract][Full Text] [Related]
8. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice. Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310 [TBL] [Abstract][Full Text] [Related]
9. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice. Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812 [TBL] [Abstract][Full Text] [Related]
10. Heterologous Boost Following Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X Front Immunol; 2018; 9():2439. PubMed ID: 30425711 [TBL] [Abstract][Full Text] [Related]
11. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis. Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH mBio; 2016 May; 7(3):. PubMed ID: 27222470 [TBL] [Abstract][Full Text] [Related]
12. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine. Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B Front Immunol; 2018; 9():2371. PubMed ID: 30386336 [TBL] [Abstract][Full Text] [Related]
13. BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design. Covián C; Fernández-Fierro A; Retamal-Díaz A; Díaz FE; Vasquez AE; Lay MK; Riedel CA; González PA; Bueno SM; Kalergis AM Front Immunol; 2019; 10():2806. PubMed ID: 31849980 [TBL] [Abstract][Full Text] [Related]
14. Intravenous BCG Vaccination of Diversity Outbred Mice Results in Moderately Enhanced Protection against Challenge with Mycobacterium tuberculosis Compared to Intradermal Vaccination. Kurtz SL; Mittereder LR; Lehman CC; Khan H; Gould VA; Elkins KL Infect Immun; 2023 Jul; 91(7):e0016823. PubMed ID: 37338410 [TBL] [Abstract][Full Text] [Related]
15. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
16. Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes. Sathkumara HD; Muruganandah V; Cooper MM; Field MA; Alim MA; Brosch R; Ketheesan N; Govan B; Rush CM; Henning L; Kupz A Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20848-20859. PubMed ID: 32778586 [TBL] [Abstract][Full Text] [Related]
17. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. Dietrich J; Andersen C; Rappuoli R; Doherty TM; Jensen CG; Andersen P J Immunol; 2006 Nov; 177(9):6353-60. PubMed ID: 17056566 [TBL] [Abstract][Full Text] [Related]
18. Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice. Xu Y; Yang E; Wang J; Li R; Li G; Liu G; Song N; Huang Q; Kong C; Wang H Immunology; 2014 Oct; 143(2):277-86. PubMed ID: 24773322 [TBL] [Abstract][Full Text] [Related]
19. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? Moliva JI; Turner J; Torrelles JB Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069 [TBL] [Abstract][Full Text] [Related]
20. A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis. Maurya SK; Aqdas M; Das DK; Singh S; Nadeem S; Kaur G; Agrewala JN BMC Infect Dis; 2020 Sep; 20(1):677. PubMed ID: 32942991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]